Heuman D - Search Results

1

Pharmacokinetic characterization of the novel pulmonary delivery excipient fumaryl diketopiperazine.

Potocka E, Cassidy JP, Haworth P, Heuman D, van Marle S, Baughman RA Jr. Potocka E, et al. Among authors: heuman d. J Diabetes Sci Technol. 2010 Sep 1;4(5):1164-73. doi: 10.1177/193229681000400515. J Diabetes Sci Technol. 2010. PMID: 20920436 Free PMC article. Clinical Trial.

2

Effects of hepatic impairment on the pharmacokinetics of nilotinib: an open-label, single-dose, parallel-group study.

Yin OQ, Gallagher N, Tanaka C, Fisher D, Sethuraman V, Zhou W, Lin TH, Heuman D, Schran H. Yin OQ, et al. Among authors: heuman d. Clin Ther. 2009;31 Pt 2:2459-69. doi: 10.1016/j.clinthera.2009.11.015. Clin Ther. 2009. PMID: 20110053 Clinical Trial.

3

Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Cabozantinib.

Nguyen L, Holland J, Ramies D, Mamelok R, Benrimoh N, Ciric S, Marbury T, Preston RA, Heuman DM, Gavis E, Lacy S. Nguyen L, et al. Among authors: heuman dm. J Clin Pharmacol. 2016 Sep;56(9):1130-40. doi: 10.1002/jcph.714. Epub 2016 Mar 23. J Clin Pharmacol. 2016. PMID: 26865195

4

Effect of hepatic impairment on the pharmacokinetics of pasireotide (SOM230): results from a multicenter phase I study.

Horsmans Y, Hu K, Ruffin M, Wang Y, Song D, Bouillaud E, Wang Y, Mazur D, Botha FP, Heuman DM. Horsmans Y, et al. Among authors: heuman dm. J Clin Pharmacol. 2012 Apr;52(4):552-8. doi: 10.1177/0091270011400072. Epub 2012 Jan 26. J Clin Pharmacol. 2012. PMID: 22282526 Clinical Trial.

5

High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics.

Habib A, Mihas AA, Abou-Assi SG, Williams LM, Gavis E, Pandak WM, Heuman DM. Habib A, et al. Clin Gastroenterol Hepatol. 2005 Mar;3(3):286-91. doi: 10.1016/s1542-3565(04)00622-6. Clin Gastroenterol Hepatol. 2005. PMID: 15765449

6

Brain Training with Video Games in Covert Hepatic Encephalopathy.

Bajaj JS, Ahluwalia V, Thacker LR, Fagan A, Gavis EA, Lennon M, Heuman DM, Fuchs M, Wade JB. Bajaj JS, et al. Am J Gastroenterol. 2017 Feb;112(2):316-324. doi: 10.1038/ajg.2016.544. Epub 2016 Dec 13. Am J Gastroenterol. 2017. PMID: 27958279 Clinical Trial.

7

Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis.

Ahluwalia V, Heuman DM, Feldman G, Wade JB, Thacker LR, Gavis E, Gilles H, Unser A, White MB, Bajaj JS. Ahluwalia V, et al. J Hepatol. 2015 Jan;62(1):75-82. doi: 10.1016/j.jhep.2014.07.033. Epub 2014 Aug 8. J Hepatol. 2015. PMID: 25111174 Free PMC article. Clinical Trial.

8

Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis.

Bajaj JS, Ellwood M, Ainger T, Burroughs T, Fagan A, Gavis EA, Heuman DM, Fuchs M, John B, Wade JB. Bajaj JS, et al. Clin Transl Gastroenterol. 2017 Jul 27;8(7):e108. doi: 10.1038/ctg.2017.38. Clin Transl Gastroenterol. 2017. PMID: 28749453 Free PMC article.

9

Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation.

Acharya C, Wade JB, Fagan A, White M, Gavis E, Ganapathy D, Gilles H, Heuman DM, Bajaj JS. Acharya C, et al. Among authors: heuman dm. Liver Transpl. 2017 Nov;23(11):1396-1403. doi: 10.1002/lt.24864. Liver Transpl. 2017. PMID: 28885772 Free PMC article.

10

Safety of an immune-enhancing nutrition supplement in cirrhotic patients with history of encephalopathy.

Abou-Assi SG, Mihas AA, Gavis EA, Gilles HS, Haselbush A, Levy JR, Habib A, Heuman DM. Abou-Assi SG, et al. JPEN J Parenter Enteral Nutr. 2006 Mar-Apr;30(2):91-6. doi: 10.1177/014860710603000291. JPEN J Parenter Enteral Nutr. 2006. PMID: 16517953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page